← Open Payments lookup

LORA DILLMAN: Open Payments

NPI 1396526992 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,114 in 132 payments from 24 companies in 2025. Trend: 2023 $36 · 2024 $1,804 · 2025 $2,114

Food & beverage: $2,114
CompanyPaymentsAmount
Novo Nordisk Inc27$405
ABBVIE INC.25$276
AstraZeneca Pharmaceuticals LP10$219
PFIZER INC.12$205
Bayer Healthcare Pharmaceuticals Inc.14$198
Lilly USA, LLC8$167
Axsome Therapeutics, Inc.3$90
Amgen Inc.5$83
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$57
Otsuka America Pharmaceutical, Inc.3$52

Products named: Ozempic, Kerendia, Wegovy, VRAYLAR, MOUNJARO, NURTEC ODT, Auvelity, FARXIGA.

Industry payments across IN — which companies pay providers there.